Oculis Holding AG

NASDAQ (USD): Oculis Holding AG (OCS)

Last Price

11.81

Today's Change

-0.14 (1.17%)

Day's Change

11.81 - 11.83

Trading Volume

1,692

Overview

Market Cap

498 Million

Shares Outstanding

41 Million

Avg Volume

16,408

Avg Price (50 Days)

11.69

Avg Price (200 Days)

11.68

PE Ratio

-7.24

EPS

-1.65

Earnings Announcement

08-Nov-2024

Previous Close

11.99

Open

11.95

Day's Range

11.94 - 11.975

Year Range

9.05 - 14.465

Trading Volume

8,837

Price Change Highlight

1 Day Change

-0.33%

5 Day Change

-0.42%

1 Month Change

3.46%

3 Month Change

0.84%

6 Month Change

1.44%

Ytd Change

8.14%

1 Year Change

-9.13%

3 Year Change

23.58%

5 Year Change

23.20%

10 Year Change

23.20%

Max Change

23.20%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment